Finance

Lists
JUBLPHARMA:NSE
Jubilant Pharmova Ltd
935,00 INR
-0,34%
(-3,20) 1D
16-окт., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JUBLPHARMA...
Open
938,20 INR
High
954,90 INR
Low
928,60 INR
Mkt. cap
148,11 млд
Avg. vol.
329,62 миң
Volume
134,97 миң
Dividend
0,53%
Quarterly dividend
1,25 INR
Ex-dividend date
2026-ж., 24-июл.
P/E ratio
42,17
52-wk high
1 184,80 INR
52-wk low
786,05 INR
EPS
22,17 INR
No. of employees
6 миң
Open
938,20 INR
High
954,90 INR
Low
928,60 INR
Mkt. cap
148,11 млд
Avg. vol.
329,62 миң
Volume
134,97 миң
Dividend
0,53%
Quarterly dividend
1,25 INR
Ex-dividend date
2026-ж., 24-июл.
P/E ratio
42,17
52-wk high
1 184,80 INR
52-wk low
786,05 INR
EPS
22,17 INR
No. of employees
6 миң
News stories
From web sources and news partners
About Jubilant Pharmova Ltd
CEO-
Employees5,66 миң
Founded1978
HeadquartersNoida, Юттар Прадеш, Индия
SectorPharmaceutical industry
Last report
2026-ж., 10-авг.
Fiscal period
Q1 2027
3,56 INR / 5,80 INR
-38,62%miss
Revenue / Est. (INR)
22,29 млд / 22,62 млд
-1,44%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
19,66 млд
21,22 млд
22,90 млд
22,29 млд
Cost of goods sold
5,96 млд
7,16 млд
9,53 млд
7,49 млд
Cost of revenue
5,96 млд
7,16 млд
9,53 млд
7,49 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,36 млд
7,06 млд
8,34 млд
7,54 млд
Operating expense
11,33 млд
12,37 млд
11,14 млд
13,60 млд
Total operating expenses
17,30 млд
19,54 млд
20,68 млд
21,09 млд
Operating income
2,37 млд
1,69 млд
2,22 млд
1,21 млд
Other non operating income
98,00 млн
205,00 млн
-369,00 млн
199,00 млн
EBT including unusual items
1,90 млд
934,00 млн
1,76 млд
864,00 млн
EBT excluding unusual items
1,96 млд
1,33 млд
1,87 млд
864,00 млн
Income tax expense
704,00 млн
376,00 млн
567,00 млн
300,00 млн
Effective tax rate
36,99%
40,26%
32,22%
34,72%
Other operating expenses
3,92 млд
4,10 млд
1,63 млд
4,79 млд
Net income
1,20 млд
559,00 млн
1,19 млд
565,00 млн
Net profit margin
6,12%
2,63%
5,21%
2,53%
Earnings per share
7,85
5,01
8,10
3,56
Interest and investment income
-
-
252,00 млн
-
Interest expense
-502,00 млн
-561,00 млн
-461,00 млн
-542,00 млн
Net interest expenses
-502,00 млн
-561,00 млн
-209,00 млн
-542,00 млн
Depreciation and amortization charges
1,05 млд
1,21 млд
1,17 млд
1,27 млд
EBITDA
3,38 млд
2,30 млд
2,98 млд
1,96 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору